Tenor Capital Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-157,732
| Closed | -$251K | – | 423 |
|
|
2023
Q1 | $251K | Buy |
157,732
+141,721
| +885% | +$225K | 0.01% | 240 |
|
|
2022
Q4 | $99.7K | Sell |
16,011
-169,827
| -91% | -$1.06M | ﹤0.01% | 346 |
|
|
2022
Q3 | $1.25M | Hold |
185,838
| – | – | 0.03% | 341 |
|
|
2022
Q2 | $1.18M | Hold |
185,838
| – | – | 0.03% | 361 |
|
|
2022
Q1 | $862K | Hold |
185,838
| – | – | 0.02% | 432 |
|
|
2021
Q4 | $929K | Buy |
+185,838
| New | +$929K | 0.02% | 434 |
|